A5002434486- Pharmaceutical Practices and Patient Outcomes
- Cardiac electrophysiology and arrhythmias
- Pharmaceutical studies and practices
- Cancer Treatment and Pharmacology
- Pharmacogenetics and Drug Metabolism
- Pharmacovigilance and Adverse Drug Reactions
- Complementary and Alternative Medicine Studies
- Lung Cancer Treatments and Mutations
- Anesthesia and Sedative Agents
- Tuberculosis Research and Epidemiology
- Analytical Methods in Pharmaceuticals
- Urinary Tract Infections Management
- Patient Safety and Medication Errors
- Pharmaceutical Economics and Policy
- Heat shock proteins research
- Heart Failure Treatment and Management
- Muscle and Compartmental Disorders
- ECG Monitoring and Analysis
- Potassium and Related Disorders
- Urticaria and Related Conditions
- Antibiotics Pharmacokinetics and Efficacy
- Cardiac pacing and defibrillation studies
- Computational Drug Discovery Methods
- Pneumonia and Respiratory Infections
- Antimicrobial Resistance in Staphylococcus
University of Peshawar
2017-2020
Khyber Teaching Hospital
2013
Abstract Background Cancer patients often receive multiple drugs to maximize their therapeutic benefit, treat co-morbidities and counter the adverse effects of chemotherapy. Concomitant administration increases risk drug interactions leading compromised efficacy or safety therapy. The purpose this study was identify prevalence, levels predictors potential drug-drug (pDDIs) among cancer patients. Methods Six hundred 78 receiving chemotherapy from two tertiary care hospitals were included in...
QT interval prolongation is a growing concern worldwide, posing psychiatric patients to life-threatening fatal arrhythmias i.e., torsade de pointes. This study aimed identify the prevalence of prolongation, its associated risk factors and prescribing patterns prolonging drugs among patients.A prospective observational was conducted that included from tertiary care hospital psychiatry clinic in Peshawar, Khyber Pakhtunkhwa, Pakistan. Electrocardiogram recorded those who were using...
Purpose: To identify the frequency, levels and predictors of potential drug-drug interactions (pDDIs) in a pediatrics ward teaching hospital Pakistan.Methods: Medication profiles 400 pediatric patients were evaluated for pDDIs using Micromedex Drug-Reax® software. Logistic regression was used to association with hospital-stay, patient’s gender, number medications.Results: In total, 86 interacting drug-combinations resulting 260 identified. Overall, 25.8 % exposed at least one pDDI regardless...
Introduction: Hospitalized patients with urinary tract infections (UTIs) often present comorbid illnesses and are subsequently prescribed multiple medications, which increase the likelihood of drug-drug interactions. Therefore, this study aimed to explore prevalence, levels, risk factors, clinical relevance potential interactions (pDDIs) in hospitalized UTIs. Secondly, we develop management guidelines identify monitoring parameters for most frequent Methods: A retrospective cross-sectional...
Background: This study aimed to measure the association of various H1-antihistamines (H1A) with Torsade de Pointes (TdP), and present a comprehensive overview H1A-induced TdP cases reported Food Drug Administration Adverse Event Reporting System (FAERS).Methods: All (n = 406) were retrieved from FAERS database using preferred term 'Torsade Pointes' MedDRA version-22 1990 2019. Four data-mining algorithms used for disproportionality analysis: Odds Ratio (ROR); Proportional (PRR), Empirical...
Abstract Background Hospitalized patients with tuberculosis (TB) are prescribed drugs having high risk of potential drug‐drug interactions (pDDIs) and adverse drug effects (ADEs). Objectives To explore the anti‐tuberculosis (anti‐TB) prevalence predictors pDDIs in hospitalized TB. Methods Clinical profiles 436 TB were reviewed for induced by anti‐TB screened using Micromedex‐DrugReax. Prevalence severity levels reported. Odds ratios calculated logistic regression analysis. Results Of total...
Hospitalized patients with left ventricular failure (LVF) are at high risk for potential drug-drug interactions (pDDIs) and its related adverse effects owing to multiple factors such as old age, comorbidities polypharmacy. This cross-sectional study conducted in two tertiary care hospitals aim identify frequency, levels predictors of pDDIs LVF patients. Data about patients’ demographic, hospital stay, medication therapy, sign/symptoms laboratory test results were collected 385 LVF....
BACKGROUND:The role of leptin, the adipokine, which has an important in maintaining energy and metabolic homeostasis myocardial infarction (MI) its complications, been great interest.METHODS: 95 patients with MI (group 1) 60 2) associated T2DM were included study; control group consisted 30 healthy subjects.Serum glucose, free fatty acids (FFA), C-peptide insulin levels measured on 1st 12th days study.MI was diagnosed according to 2007 National Scientific Cardiology Society.The study design...
Abstract Background: Cancer patients often receive multiple drugs to maximize their therapeutic benefit, treat co-morbidities and counter the adverse effects of chemotherapy. Concomitant administration increases risk drug interactions leading compromised efficacy or safety therapy. The purpose this study was identify prevalence, levels predictors potential drug-drug (pDDIs) among cancer patients. Methods: Six hundred seventy-eight receiving chemotherapy from two tertiary care hospitals were...
Abstract Background: Cancer patients often receive multiple drugs to maximize their therapeutic benefit, treat co-morbidities and counter the adverse effects of chemotherapy. Concomitant administration increases risk drug interactions leading compromised efficacy or safety therapy. The purpose this study was identify prevalence, levels predictors potential drug-drug (pDDIs) among cancer patients. Methods: Six hundred seventy-eight receiving chemotherapy from two tertiary care hospitals were...